Real-time PCR, Digital PCR, And End-point PCR Market To Reach $21.31 Billion By 2033

April 2026 | Report Format: Electronic (PDF)

Real-time PCR, Digital PCR, And End-point PCR Market Growth & Trends

The global real-time PCR, digital PCR, and end-point PCR market size is estimated to reach USD 21.31 billion by 2033, registering a CAGR of 9.2% from 2026 to 2033, according to a new report by Grand View Research, Inc. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years

The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.

Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.

Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.

Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.

key Request a free sample copy or view the report summary: Real-time PCR, Digital PCR, And End-point PCR Market Report

Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights

Based on technology, the quantitative PCR (qPCR) segment accounted for the largest revenue share, over 79.21%, in 2025, owing to its high sensitivity, accuracy, and rapid turnaround time.
Based on product, the consumables and reagents segment held the largest revenue share of over 62.88% in 2025 and it is anticipated to grow at the fastest rate over the forecast period.
Based on application, the research segment accounted for the largest revenue share of 45.95% in 2025, driven by the extensive use of PCR technologies in genomics, molecular biology, and life science research.
North America real-time PCR, digital PCR, and end-point PCR market dominated the global market and accounted for the largest revenue share of 38.58%in 2025, driven by advanced healthcare infrastructure, high adoption of molecular diagnostics, and strong presence of leading companies.

Real-time PCR, Digital PCR, And End-point PCR Market Segmentation

Grand View Research has segmented the global real time PCR, digital PCR, and end-point PCR market on the basis of technology, application, product, and regions:

Real-time PCR, Digital PCR, And End-point PCR Technology Outlook (Revenue, USD Million, 2021 - 2033)

Quantitative
- Consumables & Reagents
- Instruments
- Software & Services
Digital
- Consumables & Reagents
- Instruments
- Software & Services
End-point
- Consumables & Reagents
- Instruments
- Software & Services

Real-time PCR, Digital PCR, And End-point PCR Product Outlook (Revenue, USD Million, 2021 - 2033)

Consumables & Reagents
Instruments
Software & Services

Real-time PCR, Digital PCR, And End-point PCR Application Outlook (Revenue, USD Million, 2021 - 2033)

Clinical
- Pathogen Testing
- Oncology testing
- Blood Screening
- Liquid Biopsy
- dPCR-based Non-Invasive Prenatal Testing (NIPT)
- Others
Research
- Stem Cell Research
- DNA Cloning & Sequencing
- Recombinant DNA Technology
- Rare Mutation Detection
- Gene Expression
- Single Cell Analysis
- Microbiome Analysis
- Copy Number Variation Analysis
- Library Quantification (NGS)
- Characterization of Low-fold Changes in mRNA and miRNA Expression.
- Species Identification
- GMO Detection
- Others
Forensic